Andreas Mühler und Immunic Person-Info 

( Ich bin Andreas Mühler)
(1 - 43 von 231
)

Immunic, Inc. to Participate in Scientific and Investor Conferences...

edition.cnn.com
View market sector performance relative to the S&P 500 Index and trended stock performance over time.

Immunic AGAD HOC NEWS

www.ad-hoc-news.de
— ... Andreas Muehler, M.D., M.B.A. Chief Medical Officer and Hella Kohlhof, Ph.D, Chief Scientific Officer, will be joined by renowned key — ... Andreas Muehler, M.D., M.B.A. Chief Medical Officer and Hella Kohlhof, Ph.D, Chief Scientific Officer, will be joined by renowned key ...

FDA bewilligt IND-Antrag für Immunics IMU-838 Phase 2 Entwicklung in...

www.pressebox.de
Immunic AG, . - Die FDA hat den IND-Antrag für Immunics orales Me…ament IMU-838 bewilligt. - IND erlaubt Immunic, mit der klinisch…

Investegate |Immunic, Inc. Announcements | Immunic, Inc.: Immunic,...

www.investegate.co.uk
Investegate announcements from Immunic, Inc., Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19
+1